Home/Filings/4/0001250853-17-000073
4//SEC Filing

MORRIS TIMOTHY E 4

Accession 0001250853-17-000073

CIK 0001425205other

Filed

Aug 15, 8:00 PM ET

Accepted

Aug 16, 2:12 PM ET

Size

5.9 KB

Accession

0001250853-17-000073

Insider Transaction Report

Form 4
Period: 2017-08-14
MORRIS TIMOTHY E
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2017-08-14+250,000250,000 total
    Exercise: $5.05Exp: 2027-08-13Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of the 250,000 shares shall vest on the one-year anniversary of August 14, 2017; and (ii) the remaining options shall vest as to one-twelfth of 250,000 shares at the end of each quarter over the next two years, commencing with the first quarter following the first anniversary of August 14, 2017.

Issuer

IOVANCE BIOTHERAPEUTICS, INC.

CIK 0001425205

Entity typeother

Related Parties

1
  • filerCIK 0001191286

Filing Metadata

Form type
4
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 2:12 PM ET
Size
5.9 KB